
Professor Sam Sheppard led the research team at the Milner Centre for Evolution
Scientists from the Milner Centre for Evolution warn S. epidermidis should be taken more seriously
Forget MRSA and E.coli, there’s another bacterium that is becoming increasingly dangerous due to antibiotic resistance – and it’s present on the skin of every person on the planet.
A close relative of MRSA, Staphylococcus epidermidis, is a major cause of life-threatening infections after surgery, but it is often overlooked by clinicians and scientists because it is so abundant.
Researchers from the Milner Centre for Evolution at the University of Bath warn that the threat posed by this organism should be taken more seriously and use extra precautions for those at higher risk of infection who are due to undergo surgery.
They have identified a set of 61 genes that allow this normally harmless skin bacterium to cause life-threatening illness.
They hope that by understanding why some strains of S. epidermidis cause disease in certain circumstances, they could in the future identify which patients are most at risk of infection before undergoing surgery.
They took samples from patients who suffered infections following hip or knee joint replacement and fracture fixation operations and compared them with swab samples from the skin of healthy volunteers.
They compared the genetic variation in the whole genomes of bacteria found in samples from diseased and healthy individuals. From this they identified 61 genes in the disease-causing bacteria that weren’t present in most of the healthy samples.
Surprisingly however, there was a small number of healthy individuals who were found to be carrying the more deadly form of the bacteria without knowing it.
The disease-causing genes were found to help the bacterium grow in the bloodstream, avoid the host’s immune response, make the cell surface sticky so that the organisms can form biofilms and make the bug resistant to antibiotics.
The team published their study in Nature Communications this week.
Professor Sam Sheppard, Director of Bioinformatics at the Milner Centre for Evolution at the University of Bath, led the research. He said: “Staphlococcus epidermidis is a deadly pathogen in plain sight.
“It’s always been ignored clinically because it’s frequently been assumed that it was a contaminant in lab samples or it was simply accepted as a known risk of surgery.
“Post-surgical infections can be incredibly serious and can be fatal. Infection accounts for almost a third of deaths in the UK so I believe we should be doing more to reduce the risk if we possibly can.
“If we can identify who is most at risk of infection, we can target those patients with extra hygiene precautions before they undergo surgery.”
He added: “Because the bug is so abundant, they can evolve very fast by swapping genes with each other.
“If we do nothing to control this, there’s a risk that these disease-causing genes could spread more widely, meaning post-operative infections that are resistant to antibiotics could become even more common.”
Professor Dietrich Mack, from the Bioscientia Institute for Medical Diagnostics GmbH, Germany, said: “Prosthetic joint replacement surgery helps many patients to live independent and painfree lives, but can take a catastrophic course through S. epidermidis infection.
“These infections are difficult to diagnose and there is hope that disease-associated genes may help to separate harmless skin isolates from disease-causing S. epidermidisstrains in the clinical laboratory. This needs to be addressed in future studies.”
Learn more: The potentially deadly bacterium that’s on everyone’s skin
The Latest on: Staphylococcus epidermidis
[google_news title=”” keyword=”Staphylococcus epidermidis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Staphylococcus epidermidis
- Methicillin-Resistant Staphylococcus aureus Infection Pipeline Clinical Trials Featuring 25+ companies| DelveInsighton January 26, 2023 at 2:49 pm
New York, USA, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Methicillin-Resistant Staphylococcus aureus Infection Pipeline Clinical Trials Featuring 25+ companies| DelveInsight DelveInsight’s 'Methicillin ...
- Health Rounds: Stroke prediction tools failing Black patientson January 26, 2023 at 8:52 am
Today we look at findings from two studies published this week in prominent medical journals that highlight racial inequities in the accuracy of stroke risk prediction and in recognizing autism in ...
- Methicillin-Resistant Staphylococcus aureus Infection Pipeline Clinical Trials Featuring 25+ companies| DelveInsighton January 25, 2023 at 10:06 am
New York, USA, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Methicillin-Resistant Staphylococcus aureus Infection Pipeline Clinical Trials Featuring 25+ companies| DelveInsight Methicillin-resistant ...
- Staphylococcus aureus News and Researchon January 22, 2023 at 4:00 pm
A promising approach to control Staphylococcus aureus bacterial colonization in people-;using a probiotic instead of antibiotics-;was safe and highly effective in a Phase 2 clinical trial.
- Why staphylococcus is becoming resistant to antibiotics –Physicianon January 21, 2023 at 11:40 pm
The National Coordinator, National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Dr. Chukwuma Anyaike, has said that while staphylococcus aureus, a bacteria that can cause infection in ...
- I’m a bacteria expert - here's why you may want to rethink wearing shoes in the houseon January 18, 2023 at 5:48 am
Many people wouldn't think twice about popping outside to the bin in their slippers or letting guests keep their shoes on during a quick visit? Well, according to one bacteria expert, it might be ...
- Probiotic markedly reduces S. Aureus colonization in phase 2 trialon January 17, 2023 at 8:40 pm
A promising approach to control Staphylococcus aureus bacterial colonization in people -- using a probiotic instead of antibiotics -- was safe and highly effective in a Phase 2 clinical trial.
- Staphylococcus aureus bacteria (IMAGE)on January 17, 2023 at 9:37 am
Methicillin-resistant Staphylococcus aureus bacteria (yellow) being ingested by neutrophil (purplish blue). Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases ...
- Photodisinfection Found to Eradicate Biofilms Associated With Periprosthetic Joint Infectionson January 17, 2023 at 2:21 am
A new study published in the journal Antibiotics found that antimicrobial photodisinfection therapy (aPDT), using Ondine Biomedical Inc.’s (AIM: OBI) proprietary methylene blue-based photosensitizer ...
via Bing News